![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
Sharp’s Netherlands Facility Approved for Clinical Operations
Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received Wholesale Distribution Authorisation (WDA) and...
Clinical Trials
Catalent To Open New Clinical Supply Facility In San Diego
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, announced it...
Clinical Trials
Velesco Pharma set for clinical manufacturing capacity expansion
Pharmaceutical development and clinical manufacturing expert, Velesco Pharma, is set to triple its clinical manufacturing capacity with the purchase and fit-out of a new,...
Clinical Trials
Tagrisso approved in China as a 1st line treatment for EGFR mutated non-small cell lung cancer
AstraZeneca announced that it has received marketing authorisation from China’s National Medical Products Administration (NMPA) for Tagrisso (osimertinib) as a 1st-line treatment for adults...
Clinical Trials
Thermo Fisher Scientific Announces Collaboration to Develop Advanced Analytical Workflows for Clinical Laboratories
Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop...
Clinical Trials
Alembic Pharmaceuticals receives USFDA Approval for Fenofibrate Tablets USP 48 mg and 145 mg
Alembic Pharmaceuticals Limited announced that the Company has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Fenofibrate Tablets...
Clinical Trials
Signant Health Launches Partner Program to Team with CRO’s Committed to Improving Clinical Trials with Patient Centric Technology
Signant Health , a leading provider of technology for clinical research, launches the Signant Health Partner Program, a significant investment the company is making...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read